thiophanat-methyl 500(importazione parallela)
bernbeck llp - tiofanato-metile - gp 033496-00/017 - germania - fungicida ;
abecma infusionsdispersion von 260 bis 500 × 10e6 car-positiven lebensfähigen t-zellen
bristol-myers squibb sa - idecabtagenum vicleucelum 260-500 x 10⁶ car-positive viable t zellen - von 260 bis 500 × 10e6 car-positiven lebensfähigen t-zellen - beutel 260 bis 500 × 10e6 car-positiven lebensfähigen t-zellen: idecabtagenum vicleucelum 260-500 x 10⁶ car-positive viable t zellen, natrii chloridum, natrii gluconas, natrii acetas trihydricus, kalii chloridum, magnesii chloridum 4.5-hydricum, aqua ad iniectabile, cryostor cs10, ad praeparationem pro. - abecma ist für die behandlung von erwachsenen patienten mit rezidiviertem und refraktärem multiplem myelom indiziert, die zuvor mindestens drei therapien erhalten haben, inklusive einem immunmodulatorischen wirkstoff, einem proteasom-inhibitor und einem anti-cd38-antikörper, und welche eine progredienz zur letzten therapie gezeigt haben. - trapianto: gentherapieprodukt
cemon unda lycopodium clavatum 200ch gocce 10ml
cemon srl -
realchemie thiophanat-methyl (importazione parallela)
realchemie nederland b.v. - tiofanato-metile - pi 033496-00/005 - germania - fungicida ;
realchemie thiophanat-methyl (importazione parallela)
realchemie nederland b.v. - tiofanato-metile - gp 033496-00/016 - germania - fungicida ;
realchemie thiophanat-methyl (importazione parallela)
realchemie nederland b.v. - tiofanato-metile - gp 033496-00/014 - germania - fungicida ;
dimethyl fumarate mylan
mylan ireland limited - dimetilfumarato - sclerosi multipla recidivante-remittente - immunosoppressori - dimethyl fumarate mylan is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.
dimethyl fumarate polpharma
zaklady farmafarmaceutyczne polpharma s.aceutyczne polpharma s.a. - dimetilfumarato - sclerosi multipla recidivante-remittente - immunosoppressori - dimethyl fumarate polpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.
dimethyl fumarate teva
teva gmbh - dimetilfumarato - multiple sclerosis, relapsing-remitting; multiple sclerosis - immunosoppressori - dimethyl fumarate teva is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).
dimethyl fumarate accord
accord healthcare s.l.u. - dimetilfumarato - multiple sclerosis, relapsing-remitting; multiple sclerosis - immunosoppressori - dimethyl fumarate accord is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).